X-49237183-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_014008.5(CCDC22):c.148G>A(p.Gly50Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,210,824 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0000088 ( 0 hom., 0 hem., cov: 24)
Exomes 𝑓: 0.000021 ( 0 hom. 8 hem. )
Consequence
CCDC22
NM_014008.5 missense
NM_014008.5 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 5.89
Genes affected
CCDC22 (HGNC:28909): (coiled-coil domain containing 22) This gene encodes a protein containing a coiled-coil domain. The encoded protein functions in the regulation of NF-kB (nuclear factor kappa-light-chain-enhancer of activated B cells) by interacting with COMMD (copper metabolism Murr1 domain-containing) proteins. The mouse orthologous protein has been shown to bind copines, which are calcium-dependent, membrane-binding proteins that may function in calcium signaling. This human gene has been identified as a novel candidate gene for syndromic X-linked intellectual disability. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.38305655).
BS2
High Hemizygotes in GnomAdExome4 at 8 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC22 | NM_014008.5 | c.148G>A | p.Gly50Ser | missense_variant | 2/17 | ENST00000376227.4 | NP_054727.1 | |
CCDC22 | XM_005272599.5 | c.148G>A | p.Gly50Ser | missense_variant | 2/17 | XP_005272656.1 | ||
CCDC22 | XR_430506.4 | n.315G>A | non_coding_transcript_exon_variant | 2/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC22 | ENST00000376227.4 | c.148G>A | p.Gly50Ser | missense_variant | 2/17 | 1 | NM_014008.5 | ENSP00000365401.3 | ||
CCDC22 | ENST00000490300.1 | n.291G>A | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
CCDC22 | ENST00000496651.5 | n.289G>A | non_coding_transcript_exon_variant | 2/6 | 3 |
Frequencies
GnomAD3 genomes AF: 0.00000884 AC: 1AN: 113089Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35225
GnomAD3 genomes
AF:
AC:
1
AN:
113089
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
35225
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000548 AC: 1AN: 182645Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67167
GnomAD3 exomes
AF:
AC:
1
AN:
182645
Hom.:
AF XY:
AC XY:
0
AN XY:
67167
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000210 AC: 23AN: 1097735Hom.: 0 Cov.: 31 AF XY: 0.0000220 AC XY: 8AN XY: 363131
GnomAD4 exome
AF:
AC:
23
AN:
1097735
Hom.:
Cov.:
31
AF XY:
AC XY:
8
AN XY:
363131
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000884 AC: 1AN: 113089Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 35225
GnomAD4 genome
AF:
AC:
1
AN:
113089
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
35225
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 14, 2024 | The c.148G>A (p.G50S) alteration is located in exon 2 (coding exon 2) of the CCDC22 gene. This alteration results from a G to A substitution at nucleotide position 148, causing the glycine (G) at amino acid position 50 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MutPred
Loss of catalytic residue at G50 (P = 0.0076);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at